GERAADA评分在日本急性A型主动脉夹层术后30天死亡预测中的验证
单中心回顾性研究纳入154例2019年1月至2024年4月因急性A型主动脉夹层行急诊手术的日本患者,评估GERAADA评分对30天死亡的预测效能并与EuroSCORE II比较。GERAADA评分AUC为0.80,EuroSCORE II为0.67(P=0.07);GERAADA评分高估死亡率而EuroSCORE II低估。
要点
- GERAADA评分对30天死亡预测AUC为0.80,判别能力良好。
- GERAADA评分在本队列显著高估死亡率,EuroSCORE II则低估。
- 转诊时使用儿茶酚胺是死亡的独立预测因素。
核心结论
- GERAADA评分能准确预测日本急性A型主动脉夹层手术患者的30天死亡,判别能力与EuroSCORE II相当。
- 该评分对短期和长期结局均有稳健预测能力,可作为ATAAD手术风险分层的实用工具。
研究设计与样本
- 单中心回顾性研究,纳入2019年1月至2024年4月因急性A型主动脉夹层行急诊手术的154例患者。
- 对每例患者计算GERAADA评分与EuroSCORE II,以ROC曲线下面积(AUC)评估30天死亡预测准确性。
- 采用多因素logistic回归识别死亡的独立预测因素,并以Kaplan-Meier分析评估长期结局。
主要发现
- 30天死亡率为11.0%。
- GERAADA评分AUC为0.80,判别能力良好;EuroSCORE II AUC为0.67(P=0.07),表现中等。
- GERAADA评分在本队列显著高估死亡率,而EuroSCORE II低估死亡率。
- 死亡的独立预测因素包括转诊时使用儿茶酚胺。
- Kaplan-Meier分析显示1年生存率为79.4%,AUC为0.72,提示GERAADA评分可用于预测长期生存。
临床怎么用
- 可将GERAADA评分用于日本ATAAD急诊手术患者的术前风险分层与预后沟通。
- 使用时需注意该评分可能高估本队列的30天死亡风险,应结合临床判断解读。
局限性
- 单中心回顾性设计,样本量154例,结论外推需谨慎。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study evaluated the applicability of the German Registry of Acute Aortic Dissection Type A (GERAADA) score in predicting 30-day mortality in Japanese patients undergoing surgery for acute type A aortic dissection (ATAAD) and compared its predictive performance with that of the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II). METHODS: This single-centre retrospective study involved 154 patients who underwent emergency surgery for ATAAD between January 2019 and April 2024. The GERAADA and EuroSCORE II were calculated for each patient. Predictive accuracy for 30-day mortality was assessed using the area under the receiver operating characteristic curve (AUC). A multivariate logistic regression identified independent predictors of mortality, and long-term outcomes were evaluated using Kaplan-Meier analysis. RESULTS: The 30-day mortality rate was 11.0%. The GERAADA score showed an AUC of 0.80, indicating good discriminatory ability, while the EuroSCORE II demonstrated moderate performance with an AUC of 0.67 (P = 0.07). The GERAADA score significantly overestimated mortality in this cohort, whereas the EuroSCORE II underestimated it. Independent predictors of mortality included the use of catecholamines at referral. Kaplan-Meier analysis revealed a 1-year survival rate of 79.4% with an AUC of 0.72, demonstrating the GERAADA score's utility as a predictor of long-term survival. CONCLUSIONS: The GERAADA score provides accurate predictions of 30-day mortality in Japanese patients undergoing ATAAD surgery, comparable to the EuroSCORE II. This score demonstrates robust predictive ability for short- and long-term outcomes and may serve as a practical tool for risk stratification in ATAAD surgery.
引用
- Kotani S, Sakaguchi G. Validation of the German registry of acute aortic dissection type A score for predicting 30-day mortality after acute type A aortic dissection surgery in a single Japanese aortic centre. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39992208. doi:10.1093/icvts/ivaf037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。